The introduction of common imatinib represents a significant chance for patients battling chronic myeloid leukemia and other illnesses. Original brand-name imatinib, commonly known as Gleevec, carries a high price https://imatinib400mg270482.newsyblog.com/2460844/off-brand-imatinib-a-cost-effective-alternative